4 studies found for: ADRENOCORTICAL CARCINOMA, HEREDITARY
|1||Not yet recruiting||
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
|2||Not yet recruiting||
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
† Study has passed its completion date and status has not been verified in more than two years.